Cargando…

Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy

PURPOSE: To evaluate the sensitivity to set up the uncertainty of VMAT plans in Nasopharyngeal carcinoma (NPC) treatment by proposing a plan robustness evaluation method. METHODS: 10 patients were selected for this study. A 2-arc volumetric-modulated arc therapy (VMAT) plan was generated for each pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhen, Xiang, Xiaoyong, Zeng, Qi, Ma, Jun, Dai, Zhitao, Kang, Kailian, Bi, Suyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722041/
https://www.ncbi.nlm.nih.gov/pubmed/34980178
http://dx.doi.org/10.1186/s13014-021-01970-8
_version_ 1784625448615936000
author Ding, Zhen
Xiang, Xiaoyong
Zeng, Qi
Ma, Jun
Dai, Zhitao
Kang, Kailian
Bi, Suyan
author_facet Ding, Zhen
Xiang, Xiaoyong
Zeng, Qi
Ma, Jun
Dai, Zhitao
Kang, Kailian
Bi, Suyan
author_sort Ding, Zhen
collection PubMed
description PURPOSE: To evaluate the sensitivity to set up the uncertainty of VMAT plans in Nasopharyngeal carcinoma (NPC) treatment by proposing a plan robustness evaluation method. METHODS: 10 patients were selected for this study. A 2-arc volumetric-modulated arc therapy (VMAT) plan was generated for each patient using Varian Eclipse (13.6 Version) treatment planning system (TPS). 5 uncertainty plans (U-plans) were recalculated based on the first 5 times set-up errors acquired from cone-beam computer tomography (CBCT). The dose differences of the original plan and perturbed plan corresponded to the plan robustness for the structure. Tumor control probability (TCP) and normal tissues complication probability (NTCP) were calculated for biological evaluation. RESULTS: The mean dose differences of D(98%) and D(95%) (ΔD(98%) and ΔD(95%)) of PTVp were respectively 3.30 Gy and 2.02 Gy. The ΔD(98%) and ΔD(95%) of CTVp were 1.12 Gy and 0.58 Gy. The ΔD(98%) and ΔD(95%) of CTVn were 1.39 Gy and 1.03 Gy, distinctively lower than those in PTVn (2.8 Gy and 2.0 Gy). The CTV-to-PTV margin increased the robustness of CTVs. The ΔD(98%) and ΔD(95%) of GTVp were 0.56 Gy and 0.33 Gy. GTVn exhibited strong robustness with little variation of D(98%) (0.64 Gy) and D(95%) (0.39 Gy). No marked mean dose variations of D(mean) were seen. The mean reduction of TCP (ΔTCP) in GTVp and CTVp were respectively 0.4% and 0.3%. The mean ΔTCPs of GTVn and CTVn were 0.92% and 1.3% respectively. The CTV exhibited the largest ΔTCP (2.2%). In OARs, the brain stem exhibited weak robustness due to their locations in the vicinity of PTV. Bilateral parotid glands were sensitive to set-up uncertainty with a mean reduction of NTCP (ΔNTCP) of 6.17% (left) and 7.70% (right). The D(max) of optical nerves and lens varied slightly. CONCLUSION: VMAT plans had a strong sensitivity to set-up uncertainty in NPC radiotherapy, with increasing risk of underdose of tumor and overdose of vicinal OARs. We proposed an effective method to evaluate the plan robustness of VMAT plans. Plan robustness and complexity should be taken into account in photon radiotherapy.
format Online
Article
Text
id pubmed-8722041
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87220412022-01-06 Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy Ding, Zhen Xiang, Xiaoyong Zeng, Qi Ma, Jun Dai, Zhitao Kang, Kailian Bi, Suyan Radiat Oncol Research PURPOSE: To evaluate the sensitivity to set up the uncertainty of VMAT plans in Nasopharyngeal carcinoma (NPC) treatment by proposing a plan robustness evaluation method. METHODS: 10 patients were selected for this study. A 2-arc volumetric-modulated arc therapy (VMAT) plan was generated for each patient using Varian Eclipse (13.6 Version) treatment planning system (TPS). 5 uncertainty plans (U-plans) were recalculated based on the first 5 times set-up errors acquired from cone-beam computer tomography (CBCT). The dose differences of the original plan and perturbed plan corresponded to the plan robustness for the structure. Tumor control probability (TCP) and normal tissues complication probability (NTCP) were calculated for biological evaluation. RESULTS: The mean dose differences of D(98%) and D(95%) (ΔD(98%) and ΔD(95%)) of PTVp were respectively 3.30 Gy and 2.02 Gy. The ΔD(98%) and ΔD(95%) of CTVp were 1.12 Gy and 0.58 Gy. The ΔD(98%) and ΔD(95%) of CTVn were 1.39 Gy and 1.03 Gy, distinctively lower than those in PTVn (2.8 Gy and 2.0 Gy). The CTV-to-PTV margin increased the robustness of CTVs. The ΔD(98%) and ΔD(95%) of GTVp were 0.56 Gy and 0.33 Gy. GTVn exhibited strong robustness with little variation of D(98%) (0.64 Gy) and D(95%) (0.39 Gy). No marked mean dose variations of D(mean) were seen. The mean reduction of TCP (ΔTCP) in GTVp and CTVp were respectively 0.4% and 0.3%. The mean ΔTCPs of GTVn and CTVn were 0.92% and 1.3% respectively. The CTV exhibited the largest ΔTCP (2.2%). In OARs, the brain stem exhibited weak robustness due to their locations in the vicinity of PTV. Bilateral parotid glands were sensitive to set-up uncertainty with a mean reduction of NTCP (ΔNTCP) of 6.17% (left) and 7.70% (right). The D(max) of optical nerves and lens varied slightly. CONCLUSION: VMAT plans had a strong sensitivity to set-up uncertainty in NPC radiotherapy, with increasing risk of underdose of tumor and overdose of vicinal OARs. We proposed an effective method to evaluate the plan robustness of VMAT plans. Plan robustness and complexity should be taken into account in photon radiotherapy. BioMed Central 2022-01-03 /pmc/articles/PMC8722041/ /pubmed/34980178 http://dx.doi.org/10.1186/s13014-021-01970-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ding, Zhen
Xiang, Xiaoyong
Zeng, Qi
Ma, Jun
Dai, Zhitao
Kang, Kailian
Bi, Suyan
Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy
title Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy
title_full Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy
title_fullStr Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy
title_full_unstemmed Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy
title_short Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy
title_sort evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (vmat) with set-up uncertainty in nasopharyngeal carcinoma (npc) radiotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722041/
https://www.ncbi.nlm.nih.gov/pubmed/34980178
http://dx.doi.org/10.1186/s13014-021-01970-8
work_keys_str_mv AT dingzhen evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy
AT xiangxiaoyong evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy
AT zengqi evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy
AT majun evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy
AT daizhitao evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy
AT kangkailian evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy
AT bisuyan evaluationofplanrobustnessonthedosimetryofvolumetricarcradiotherapyvmatwithsetupuncertaintyinnasopharyngealcarcinomanpcradiotherapy